Mark Soloway

Summary

Affiliation: University of Miami
Country: USA

Publications

  1. ncbi Active surveillance; a reasonable management alternative for patients with prostate cancer: the Miami experience
    Mark S Soloway
    Department of Urology, University of Miami Miller School of Medicine, Miami, Florida 33101, USA
    BJU Int 101:165-9. 2008
  2. ncbi Young man with locally advanced prostate cancer
    Mark Soloway
    University of Miami, Miller School of Medicine, Department of Urology, Miami, FL 33136, USA
    Curr Urol Rep 8:181-2. 2007
  3. ncbi Careful selection and close monitoring of low-risk prostate cancer patients on active surveillance minimizes the need for treatment
    Mark S Soloway
    Department of Urology, Miller School of Medicine, University of Miami, Miami, Florida, USA
    Eur Urol 58:831-5. 2010
  4. ncbi A 79-year-old man with urothelial carcinoma of the bladder and upper urinary tract
    Mark Soloway
    Department of Urology, University of Miami, Miller School of Medicine, Dominion Towers, 1400 NW 10th Avenue, Suite 506, Miami, FL 33136, USA
    Curr Urol Rep 8:349-50. 2007
  5. ncbi A small mass in a single testis after orchiectomy for testis cancer
    Mark Soloway
    Department of Urology, University of Miami, Miller School of Medicine, Dominion Towers, 1400 NW 10th Avenue, Suite 506, Miami, FL 33136, USA
    Curr Urol Rep 9:3-4. 2008
  6. ncbi Radical cystectomy for BCG failure: has the timing improved in recent years?
    Mark S Soloway
    Department of Urology, University of Miami Miller School of Medicine, Miami, FL 33101, USA
    BJU Int 108:182-5. 2011
  7. ncbi High-grade T1 bladder cancer at the ureterovesical junction
    Mark Soloway
    University of Miami, Miller School of Medicine, Department of Urology, Dominion Towers, 1400 NW, 10th Avenue, Suite 506, Miami, FL 33136, USA
    Curr Urol Rep 8:104-7. 2007
  8. ncbi Difficult decisions in urologic oncology: management of high-grade T1 transitional cell carcinoma of the bladder
    Mark S Soloway
    Department of Urology, University of Miami Jackson Memorial Hospital, Miami, FL 33101, USA
    Urol Oncol 25:338-40. 2007
  9. ncbi En bloc mobilization of the pancreas and spleen to facilitate resection of large tumors, primarily renal and adrenal, in the left upper quadrant of the abdomen: techniques derived from multivisceral transplantation
    Gaetano Ciancio
    Department of Surgery, Division of Transplantation, University of Miami School of Medicine, Miami, Florida 33101, USA
    Eur Urol 55:1106-11. 2009
  10. ncbi Marital satisfaction of advanced prostate cancer survivors and their spousal caregivers: the dyadic effects of physical and mental health
    Eric S Zhou
    Department of Psychology, University of Miami, Coral Gables, FL 33124 0751, USA
    Psychooncology 20:1353-7. 2011

Detail Information

Publications97

  1. ncbi Active surveillance; a reasonable management alternative for patients with prostate cancer: the Miami experience
    Mark S Soloway
    Department of Urology, University of Miami Miller School of Medicine, Miami, Florida 33101, USA
    BJU Int 101:165-9. 2008
    ..To examine the outcome of patients diagnosed with 'low-risk' prostate cancer managed by active surveillance (AS)...
  2. ncbi Young man with locally advanced prostate cancer
    Mark Soloway
    University of Miami, Miller School of Medicine, Department of Urology, Miami, FL 33136, USA
    Curr Urol Rep 8:181-2. 2007
  3. ncbi Careful selection and close monitoring of low-risk prostate cancer patients on active surveillance minimizes the need for treatment
    Mark S Soloway
    Department of Urology, Miller School of Medicine, University of Miami, Miami, Florida, USA
    Eur Urol 58:831-5. 2010
    ..Because > 97% of men with LRPC are likely to die of something other than prostate cancer, it is critical that patients give thought to whether early curative treatment is the only option at diagnosis...
  4. ncbi A 79-year-old man with urothelial carcinoma of the bladder and upper urinary tract
    Mark Soloway
    Department of Urology, University of Miami, Miller School of Medicine, Dominion Towers, 1400 NW 10th Avenue, Suite 506, Miami, FL 33136, USA
    Curr Urol Rep 8:349-50. 2007
  5. ncbi A small mass in a single testis after orchiectomy for testis cancer
    Mark Soloway
    Department of Urology, University of Miami, Miller School of Medicine, Dominion Towers, 1400 NW 10th Avenue, Suite 506, Miami, FL 33136, USA
    Curr Urol Rep 9:3-4. 2008
  6. ncbi Radical cystectomy for BCG failure: has the timing improved in recent years?
    Mark S Soloway
    Department of Urology, University of Miami Miller School of Medicine, Miami, FL 33101, USA
    BJU Int 108:182-5. 2011
    ..Although BCG is indicated for prophylaxis after endoscopic tumour resection there is still a risk of progression...
  7. ncbi High-grade T1 bladder cancer at the ureterovesical junction
    Mark Soloway
    University of Miami, Miller School of Medicine, Department of Urology, Dominion Towers, 1400 NW, 10th Avenue, Suite 506, Miami, FL 33136, USA
    Curr Urol Rep 8:104-7. 2007
  8. ncbi Difficult decisions in urologic oncology: management of high-grade T1 transitional cell carcinoma of the bladder
    Mark S Soloway
    Department of Urology, University of Miami Jackson Memorial Hospital, Miami, FL 33101, USA
    Urol Oncol 25:338-40. 2007
    ..Radical cystectomy as well as transurethral resection followed by intravesical BCG are acceptable initial therapies. This article reviews these treatment options and provides recommendations for management of high grade T1 tumors...
  9. ncbi En bloc mobilization of the pancreas and spleen to facilitate resection of large tumors, primarily renal and adrenal, in the left upper quadrant of the abdomen: techniques derived from multivisceral transplantation
    Gaetano Ciancio
    Department of Surgery, Division of Transplantation, University of Miami School of Medicine, Miami, Florida 33101, USA
    Eur Urol 55:1106-11. 2009
    ..When these lesions are large, safely resecting them often presents a significant technical challenge, with the possibility of resultant morbidity and mortality...
  10. ncbi Marital satisfaction of advanced prostate cancer survivors and their spousal caregivers: the dyadic effects of physical and mental health
    Eric S Zhou
    Department of Psychology, University of Miami, Coral Gables, FL 33124 0751, USA
    Psychooncology 20:1353-7. 2011
    ..The current study sought to: (1) document levels of physical and mental health, and marital satisfaction, and (2) evaluate the relationship between physical and mental health with marital satisfaction in this understudied population...
  11. ncbi Surveillance for recurrent bladder cancer using a point-of-care proteomic assay
    H Barton Grossman
    Department of Urology, M. D. Anderson Cancer Center, Houston, Tex 77030, USA
    JAMA 295:299-305. 2006
    ..2%; 95% CI, 87.7%-97.8%; P = .08). CONCLUSION: The noninvasive point-of-care assay for elevated urinary NMP22 protein can increase the ability to detect recurrent bladder cancer, with test results available during the patient visit...
  12. ncbi Perceived stress mediates the effects of social support on health-related quality of life among men treated for localized prostate cancer
    Eric S Zhou
    Department of Psychology, University of Miami, P O Box 248185 Coral Gables, FL 33124, USA
    J Psychosom Res 69:587-90. 2010
    ....
  13. ncbi Intravesical therapy for bladder cancer
    Steve K Williams
    Department of Urology, Albert Einstein College of Medicine, Bronx, NY 10467, USA
    Expert Opin Pharmacother 11:947-58. 2010
    ..Adjuvant therapy is effective in avoiding post-TURBT implantation of tumor cells, eradicating residual disease, preventing tumor recurrence, and to delay or reduce tumor progression through direct cytoablation or immunostimulation...
  14. ncbi Comparison of the prognostic potential of hyaluronic acid, hyaluronidase (HYAL-1), CD44v6 and microvessel density for prostate cancer
    Sinan Ekici
    Department of Urology, University of Miami School of Medicine, Miami, FL 33101, USA
    Int J Cancer 112:121-9. 2004
    ..In our retrospective study with 72- to 131-month follow-up, EPE, preoperative PSA and HYAL-1 either alone or together with HA (i.e., combined HA-HYAL-1) were independent prognostic indicators for PCa...
  15. ncbi Lack of progress in early diagnosis of bladder cancer
    Motoo Araki
    Department of Urology, University of Miami Miller School of Medicine, Miami Beach, Florida 33140, USA
    Urology 69:270-4. 2007
    ..Recently, strides have been made in the validation, development, and approval of bladder cancer (BC) markers. We sought to evaluate whether any stage migration has occurred for patients with BC during the same period...
  16. ncbi Impact of risk factors on the performance of the nuclear matrix protein 22 point-of-care test for bladder cancer detection
    Yair Lotan
    Department of Urology, University of Texas, Southwestern Medical Center, Dallas, TX 75390, USA
    BJU Int 101:1362-7. 2008
    ..Newton, MA, USA) for the detection of bladder cancer, as this is a point-of-care assay that measures NMPs in voided urine...
  17. ncbi Resection of the abdominal inferior vena cava for complicated renal cell carcinoma with tumour thrombus
    Gaetano Ciancio
    Department of Surgery Division of Transplantation, University of Miami School of Medicine, Miami, FL 33101, USA
    BJU Int 96:815-8. 2005
    ....
  18. ncbi Radical cystectomy for urothelial carcinoma of the bladder: an analysis of perioperative and survival outcome
    Murugesan Manoharan
    Department of Urology, Miller School of Medicine, University of Miami, Miami, FL 33101, USA
    BJU Int 104:1227-32. 2009
    ..To review the outcomes in a large group of patients treated with radical cystectomy (RC) for urothelial cancer (UC) of the bladder, by one surgical team...
  19. ncbi Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study
    Alan M Nieder
    Department of Urology, University of Miami Miller School of Medicine, Miami, Florida, USA
    J Urol 180:2005-9; discussion 2009-10. 2008
    ..We estimated the risk of secondary bladder cancer and rectal cancer after prostate radiotherapy using a contemporary population based cohort...
  20. ncbi HYAL-1 hyaluronidase: a potential prognostic indicator for progression to muscle invasion and recurrence in bladder cancer
    Mario W Kramer
    Department of Urology, University of Miami Miller School of Medicine, Miami, FL 33101, USA
    Eur Urol 57:86-93. 2010
    ..Hyaluronoglucosaminidase 1 (HYAL-1)-type hyaluronidase (HAase) promotes tumor growth, invasion, and angiogenesis. Urinary HA and HAase levels are diagnostic markers for BCa...
  21. ncbi Osteopontin and interleukin-8 expression is independently associated with prostate cancer recurrence
    Daniel J Caruso
    Department of Urology, Miller School of Medicine, University of Miami, Miami, FL 33101, USA
    Clin Cancer Res 14:4111-8. 2008
    ..The two inflammatory chemokines, osteopontin and interleukin-8 (IL-8), are associated with tumor angiogenesis and metastasis. We investigated whether osteopontin and IL-8 expression in prostate cancer correlates with disease progression...
  22. ncbi Recurrence of prostate cancer after radical prostatectomy in a 57-year-old man
    Mark Soloway
    Department of Urology, University of Miami, Miller School of Medicine, Dominion Towers, 1400 NW 10th Avenue, Suite 506, Miami, FL 33136, USA
    Curr Urol Rep 9:91-3. 2008
  23. ncbi Surgical management of renal cell carcinoma with tumor thrombus in the renal and inferior vena cava: the University of Miami experience in using liver transplantation techniques
    Gaetano Ciancio
    Department of Surgery, Division of Transplantation, University of Miami Miller School of Medicine, Miami, Florida, USA
    Eur Urol 51:988-94; discussion 994-5. 2007
    ..We developed a technique for safe resection of these tumors through a transabdominal approach, without recourse to cardiopulmonary bypass (CPB)...
  24. ncbi Limitations of biopsy Gleason grade: implications for counseling patients with biopsy Gleason score 6 prostate cancer
    Paul D Sved
    Department of Urology, University of Miami School of Medicine, Miami, Florida, USA
    J Urol 172:98-102. 2004
    ..Patients with biopsy Gleason score 6 who are under graded are at significantly higher risk for adverse pathological features and biochemical recurrence than patients who remain with Gleason score 6 or less on final pathology findings...
  25. ncbi Positive surgical margins after radical retropubic prostatectomy: the influence of site and number on progression
    Mario Sofer
    Department of Urology, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida, USA
    J Urol 167:2453-6. 2002
    ..However, multiple positive margins are associated with a significantly increased risk of biochemical recurrence. Longer followup and larger sample size are necessary to confirm these findings...
  26. ncbi Tumor thrombus involving the inferior vena cava in renal malignancy: is there a difference in clinical presentation and outcome among right and left side tumors?
    Devendar Katkoori
    Department of Urology, Miller School of Medicine, University of Miami, Miami, Florida 33101, USA
    Int Braz J Urol 35:652-6; discussion 656-7. 2009
    ..Due to inherent differences in the venous anatomy of the right and left kidneys, tumor thrombus involvement of IVC may vary. The aim of this study is to compare clinical presentation and outcome of right vs. left RCC with IVC thrombus...
  27. ncbi Techniques for avoidance of sternotomy and cardiopulmonary bypass during resection of extensive renal cell carcinoma with vena caval tumor thrombus extension above the diaphragm
    Gaetano Ciancio
    Division of Transplantation, Department of Surgery, University of Miami Miller School of Medicine and Jackson Memorial Hospital, Miami, Florida, USA
    J Card Surg 24:657-60. 2009
    ....
  28. ncbi Urethral recurrence after cystoprostatectomy: implications for urinary diversion and monitoring
    Alan M Nieder
    Department of Urology, University of Miami School of Medicine, Miami, Florida 33101, USA
    Urology 64:950-4. 2004
    ..An orthotopic neobladder can therefore be safely considered in most patients. Delayed urethrectomy can be safely performed in those few patients with isolated urethral recurrence without compromising their survival...
  29. ncbi Longitudinal effects of social support and adaptive coping on the emotional well-being of survivors of localized prostate cancer
    Eric S Zhou
    Department of Psychology, University of Miami, Coral Gables, Miami, Florida 33124, USA
    J Support Oncol 8:196-201. 2010
    ..Attention should be given to strengthening social support networks and educating survivors of prostate cancer on adaptive coping techniques...
  30. ncbi Hyaluronic acid and HYAL-1 in prostate biopsy specimens: predictors of biochemical recurrence
    Christopher S Gomez
    Department of Urology, University of Miami Miller School of Medicine, Miami, Florida 33101, USA
    J Urol 182:1350-6. 2009
    ..We examined whether hyaluronic acid and HYAL-1 staining in biopsy specimens predicts biochemical recurrence and correlates with staining in matched prostatectomy specimens...
  31. ncbi HYAL1-v1, an alternatively spliced variant of HYAL1 hyaluronidase: a negative regulator of bladder cancer
    Vinata B Lokeshwar
    Department of Urology, University of Miami Miller School of Medicine, Miami, Florida 33101, USA
    Cancer Res 66:11219-27. 2006
    ..Therefore, HYAL-v1 expression may negatively regulate bladder tumor growth, infiltration, and angiogenesis...
  32. ncbi Metastatic adenoid cystic carcinoma to the kidney in a young woman
    M Manoharan
    Department of Urology, University of Miami Miller School of Medicine, Miami, Florida 33101, USA
    Urology 68:1343.e11-2. 2006
    ..During follow-up, the patient developed pulmonary nodules that were metastatic adenoid cystic carcinoma and were surgically excised. At last follow-up, the patient was doing well with no evidence of disease...
  33. ncbi Orthotopic ileal neobladder reconstruction for bladder cancer: is adjuvant chemotherapy safe?
    Murugesan Manoharan
    Department of Urology, University of Miami School of Medicine, Miami, FL 33101, USA
    Int Braz J Urol 32:529-35. 2006
    ..We examined our database of patients undergoing radical cystectomy (RC) with orthotopic neobladder (NB) to determine whether adjuvant chemotherapy in this group is safe...
  34. ncbi Epigenetic targets in the diagnosis and treatment of prostate cancer
    Murugesan Manoharan
    Department of Urology, Miller School of Medicine, University of Miami, Miami, Florida 33101, USA
    Int Braz J Urol 33:11-8. 2007
    ..In this review, we discuss epigenetic changes associated with PC and their potential diagnostic and therapeutic applications including future areas of research...
  35. ncbi Serum free circulating DNA is a useful biomarker to distinguish benign versus malignant prostate disease
    Edna Gordian
    Sylvester Comprehensive Cancer Center, University of Miami School of Medicine, 1475 N W 12th Avenue, Miami, FL 33136, USA
    Cancer Epidemiol Biomarkers Prev 19:1984-91. 2010
    ..Our study examined the use of serum fcDNA levels as a biomarker of prostate cancer in such a setting...
  36. ncbi Contemporary open partial nephrectomy is associated with diminished procedure-specific morbidity despite increasing technical challenges: a single institutional experience
    Bruce R Kava
    Department of Urology, Miller School of Medicine, University of Miami, PO Box 016960 M814, Miami, FL 33101, USA
    World J Urol 28:507-12. 2010
    ..To review trends in open partial nephrectomy (OPN) at our center, concentrating on patient selection, technique and perioperative complications...
  37. ncbi Renal carcinoma with supradiaphragmatic tumor thrombus: avoiding sternotomy and cardiopulmonary bypass
    Gaetano Ciancio
    Department of Surgery, Division of Transplantation, University of Miami Miller School of Medicine, Miami, Florida 33101, USA
    Ann Thorac Surg 89:505-10. 2010
    ..Clinical outcomes of these patients and techniques are reported...
  38. ncbi Prostatic involvement by urothelial carcinoma of the bladder: clinicopathological features and outcome after radical cystectomy
    Rajinikanth Ayyathurai
    Department of Urology, University of Miami Miller School of Medicine, Miami, FL, USA
    BJU Int 100:1021-5. 2007
    ....
  39. ncbi Neoadjuvant androgen ablation before radical prostatectomy in cT2bNxMo prostate cancer: 5-year results
    Mark S Soloway
    Department of Urology, University of Miami Medical School, Miami, FL, USA
    J Urol 167:112-6. 2002
    ..Until studies document improvement in biochemical or clinical recurrence with longer periods of treatment, induction androgen deprivation before radical prostatectomy is not indicated...
  40. ncbi Vascular stapling of the inferior vena cava: further refinement of techniques for the excision of extensive renal cell carcinoma with unresectable vena-caval involvement
    Samir P Shirodkar
    Department of Urology, University of Miami School of Medicine, Miami, Florida, USA
    Urology 74:846-50. 2009
    ..Options for tumor excision include thrombectomy with or without cardiopulmonary bypass, replacement of the cava with synthetic or venous graft, or caval excision without replacement...
  41. ncbi Lymphovascular invasion in radical cystectomy specimen: is it an independent prognostic factor in patients without lymph node metastases?
    Murugesan Manoharan
    Department of Urology, Miller School of Medicine, University of Miami, P O Box 016960 M814, Miami, FL 33101, USA
    World J Urol 28:233-7. 2010
    ..To determine the prognostic significance of lymphovascular invasion (LVI) in patients with urothelial carcinoma of the bladder undergoing radical cystectomy (RC) and bilateral pelvic lymph node dissection...
  42. ncbi Outcome after radical cystectomy in patients with clinical T2 bladder cancer in whom neoadjuvant chemotherapy has failed
    Murugesan Manoharan
    Departments of Urology and Medicine, Miller School of Medicine, University of Miami, Miami, FL 33101, USA
    BJU Int 104:1646-9. 2009
    ..To analyse the outcome after radical cystectomy (RC) in patients with clinical T2 bladder cancer not responding to neoadjuvant chemotherapy (NAC)...
  43. ncbi Epigenetic regulation of HYAL-1 hyaluronidase expression. identification of HYAL-1 promoter
    Vinata B Lokeshwar
    Department of Urology, University of Miami Miller School of Medicine, Miami, Florida 33101, USA
    J Biol Chem 283:29215-27. 2008
    ..Thus, HYAL-1 expression is epigenetically regulated by the binding of different transcription factors to the methylated and unmethylated HYAL-1 promoter...
  44. ncbi Concurrent radical retropubic prostatectomy and Lichtenstein inguinal hernia repair through a single modified Pfannenstiel incision: a 3-year experience
    Murugesan Manoharan
    Department of Urology, Miller School of Medicine, University of Miami, Miami, FL 33101, USA
    BJU Int 98:341-4. 2006
    ....
  45. ncbi Expectant treatment of small, recurrent, low-grade, noninvasive tumors of the urinary bladder
    Mark S Soloway
    Department of Urology, University of Miami, Miller School of Medicine, Miami, FL 33136, USA
    Urol Oncol 24:58-61. 2006
    ..Once a patient has a history of low-grade papillary tumors and a subsequent low-grade appearing tumor, there is no urgency to proceed with treatment. The growth rate of these tumors is slow and they rarely progress...
  46. ncbi Radical retropubic prostatectomy in Hispanic patients
    Pablo Gomez
    Department of Urology, University of Miami School of Medicine, Miami, Florida 33101, USA
    Cancer 100:1628-32. 2004
    ..CONCLUSIONS: Hispanic patients managed with radical prostatectomy for prostate carcinoma were found to have similar presentation, pathologic findings, and outcome as the white non-Hispanic patients...
  47. ncbi Optimal management of the T1G3 bladder cancer
    Murugesan Manoharan
    Department of Urology, University of Miami School of Medicine, 1400 NW 10th Avenue, 506, Miami, FL 33136, USA
    Urol Clin North Am 32:133-45. 2005
    ..The discovery of reliable markers may contribute to better selection of patients for bladder sparing. Until then, the optimal treatment for the T1G3 tumor remains controversial...
  48. ncbi Biochemical and pathological predictors of the recurrence of prostatic adenocarcinoma with seminal vesicle invasion
    Mario Sofer
    Departments of Urology and Pathology, University of Miami, Miami, Florida, USA
    J Urol 169:153-6. 2003
    ..Hopefully future randomized trials may show a survival benefit of adjuvant therapy in patients at high risk...
  49. ncbi Bladder tumor markers for monitoring recurrence and screening comparison of hyaluronic acid-hyaluronidase and BTA-Stat tests
    Vinata B Lokeshwar
    Department of Urology, University of Miami School of Medicine, Miami, Florida 33101, USA
    Cancer 95:61-72. 2002
    ..The authors examined the efficacy of the hyaluronic acid-hyaluronidase (HA-HAase) and BTA-Stat tests to detect and predict bladder carcinoma recurrence and tested their specificity for bladder carcinoma screening...
  50. ncbi Intraoperative cell salvage during radical cystectomy does not affect long-term survival
    Alan M Nieder
    Department of Urology, University of Miami Miller School of Medicine, Miami, Florida 33140, USA
    Urology 69:881-4. 2007
    ..To evaluate the risk of long-term recurrence for patients who received cell-salvaged blood during radical cystectomy (RC)...
  51. ncbi Evaluation of the prognostic potential of hyaluronic acid and hyaluronidase (HYAL1) for prostate cancer
    J Timothy Posey
    Department of Urology, University of Miami School of Medicine, Miami, Florida 33101, USA
    Cancer Res 63:2638-44. 2003
    ..42; P = 0.009), HA-HYAL1 (OR = 18.048; P = 0.0033), and margin (OR = 26.948; P = 0.006)] were significant. Thus, in this 5-year follow-up study, HYAL1, together with EPE and margin, was found to be an independent prognostic indicator...
  52. ncbi Regulation of hyaluronidase activity by alternative mRNA splicing
    Vinata B Lokeshwar
    Department of Urology M 800, University of Miami School of Medicine, Miami, FL 33101, USA
    J Biol Chem 277:33654-63. 2002
    ..These results demonstrate that alternative mRNA splicing controls cellular expression of enzymatically active hyaluronidase and may explain the elevated hyaluronidase levels in bladder/prostate cancer...
  53. ncbi Renal cell carcinoma with tumor thrombus extending above diaphragm: avoiding cardiopulmonary bypass
    Gaetano Ciancio
    Division of Transplantation, Department of Surgery, University of Miami School of Medicine, Miami, Florida 33101, USA
    Urology 66:266-70. 2005
    ..1 months, and 5 patients were disease free. CONCLUSIONS: In select cases, renal cell carcinoma extending into the supradiaphragmatic IVC and right atrium can be resected without the use of CPB. We describe our technique...
  54. ncbi Sexual, psychological and dyadic qualities of the prostate cancer 'couple'
    Cynthia T Soloway
    Department of Urology, University of Miami School of Medicine, Miami, Florida, USA
    BJU Int 95:780-5. 2005
    ....
  55. ncbi Risk of positive margins and biochemical recurrence in relation to nerve-sparing radical prostatectomy
    Mario Sofer
    Department of Urology, University of Miami, FL 33101, USA
    J Clin Oncol 20:1853-8. 2002
    ..Given our experience, we recommend preservation of neurovascular bundles in these patients whenever the procedure is technically feasible...
  56. ncbi Cyclooxygenase-2 (COX-2) expression is an independent predictor of prostate cancer recurrence
    Brian L Cohen
    Department of Urology, Miller School of Medicine, University of Miami, FL 33101, USA
    Int J Cancer 119:1082-7. 2006
    ..COX-2 expression is an independent predictor of prostate cancer progression following RP and underscores the significance of inflammatory factors in this process...
  57. ncbi Radical cystectomy after bacillus Calmette-Guérin for high-risk Ta, T1, and carcinoma in situ: defining the risk of initial bladder preservation
    Alan M Nieder
    Department of Urology, University of Miami Miller School of Medicine, Miami, Florida 33140, USA
    Urology 67:737-41. 2006
    ..To critically evaluate the survival of patients with high-grade Ta or T1 urothelial cancer (UC) or carcinoma in situ of the bladder who have received bacillus Calmette-Guérin (BCG) and who have undergone radical cystectomy...
  58. ncbi A 49-year-old Hispanic male with intraepithelial neoplasia and focal atypia
    Mark Soloway
    Department of Urology, University of Miami, Miller School of Medicine, Dominion Towers, 1400 NW 10th Avenue, Suite 506, Miami, FL 33136, USA
    Curr Urol Rep 9:342-5. 2008
  59. ncbi Prostate cancer progression after therapy of primary curative intent: a review of data from prostate-specific antigen era
    Mark Soloway
    Department of Urology, University of Miami School of Medicine, Miami, Florida 33136, USA
    Cancer 104:2310-22. 2005
    ..However, these therapies are not curative in all patients and, consequently, a substantial proportion of treated patients remain at risk of disease progression and/or cancer-related death...
  60. ncbi The use of natural veno-venous bypass during surgical treatment of renal cell carcinoma with inferior vena cava thrombus
    Gaetano Ciancio
    Department of Surgery, University of Miami School of Medicine, Florida 33101, USA
    Am Surg 68:488-90. 2002
    ..These natural veno-venous bypasses allow vascular isolation of the inferior vena cava without disturbing the venous return to the heart and thereby help to prevent hemodynamic instability...
  61. ncbi Visual estimate of percent of carcinoma predicts recurrence after radical prostatectomy
    M Manoharan
    Department of Urology, University of Miami School of Medicine, Florida, USA
    J Urol 170:1194-8. 2003
    ..1% to 20%) and 2.7 for the high VEPC group (greater than 20%). In the reference group it was less than 9% (low volume). CONCLUSIONS: VEPC is a simple and inexpensive method that is an independent predictor of recurrence after RP...
  62. ncbi Cystoprostatectomy and orthotopic ileal neobladder reconstruction for management of bacille Calmette Guérin-induced bladder contractures
    Alan M Nieder
    Department of Urology, University of Miami School of Medicine, Miami, Florida 33101, USA
    Urology 65:909-12. 2005
    ..Cystoprostatectomy with orthotopic neobladder reconstruction may be the optimal solution to alleviate severe lower urinary tract symptoms and remove the risk of subsequent urothelial malignancy...
  63. ncbi A prospective study measuring penile length in men treated with radical prostatectomy for prostate cancer
    Marc Savoie
    Department of Urology, University of Miami School of Medicine, Florida, USA
    J Urol 169:1462-4. 2003
    ..501, p = 0.609). CONCLUSIONS: Our findings support observations of decreased penile length after radical prostatectomy. Men should be counseled before radical prostatectomy that penile shortening may occur...
  64. ncbi Intraoperative cell salvage during radical prostatectomy is not associated with greater biochemical recurrence rate
    Alan M Nieder
    Department of Urology, University of Miami School of Medicine, Miami, Florida 33101, USA
    Urology 65:730-4. 2005
    ..The risk of biochemical recurrence was not increased for those who received cell-salvaged blood. Concerns about spreading tumor cells by way of IOCS would seem unwarranted...
  65. ncbi Radionuclide bone scintigraphy in patients with biochemical recurrence after radical prostatectomy: when is it indicated?
    Pablo Gomez
    Department of Urology, University of Miami School of Medicine, Miami, FL 33101, USA
    BJU Int 94:299-302. 2004
    ..To evaluate the use of radionuclide bone scintigraphy following biochemical recurrence after radical retropubic prostatectomy (RRP) for localized prostate cancer...
  66. ncbi Complications of intravesical therapy for urothelial cancer of the bladder
    Madhusudan P Koya
    Department of Urology, University of Miami School of Medicine, Miami, Florida 33136, USA
    J Urol 175:2004-10. 2006
    ..Adherence to guidelines may prevent inappropriate use, which can lead to unnecessary complications, resulting in bladder dysfunction and even cystectomy...
  67. ncbi Renal cell cancer with invasive atrial tumor thrombus excised off-pump
    Wolfgang H Cerwinka
    Department of Urology, University of Miami Miller School of Medicine, Miami, Florida, USA
    Urology 66:1319. 2005
    ..The invasive tumor thrombus was sharply excised off the atrial wall. If serious medical conditions do not permit the use of cardiopulmonary bypass, it is technically feasible to excise a wall-invasive atrial tumor thrombus off-pump...
  68. ncbi Basal cell carcinoma of the prostate: current concepts
    Rajinikanth Ayyathurai
    Department of Urology, University of Miami Miller School of Medicine, Miami, FL 33101, USA
    BJU Int 99:1345-9. 2007
  69. ncbi Prostate specific antigen recurrence rates are low after radical retropubic prostatectomy and positive margins
    Michael A Simon
    Department of Urology, University of Miami School of Medicine, Miami, Florida, USA
    J Urol 175:140-4; discussion 144-5. 2006
    ..It is important to consider other factors, such as PSA, Gleason score, seminal vesicle involvement and extraprostatic extension, when making treatment decisions...
  70. ncbi HAS1 expression in bladder cancer and its relation to urinary HA test
    Roozbeh Golshani
    Department of Cell Biology, University of Miami Miller School of Medicine, Miami, Florida 33101, USA
    Int J Cancer 120:1712-20. 2007
    ..05) and possibly disease progression (p = 0.058). Therefore, elevated HAS1 expression in bladder tumor tissues contributes to a positive HA urine test and may have some prognostic potential...
  71. ncbi En bloc mobilization of the inferior vena cava and large hypervascular right renal tumors with or without inferior vena cava thrombus: Posterior ligation of the renal artery
    Gaetano Ciancio
    Department of Surgery (Division of Transplantation, University of Miami Miller School of Medicine, Miami, Florida, USA
    Int J Urol 13:1144-6. 2006
    ..In our experience, the use of this posterior approach for renal artery ligation is safe and effective, even with large renal tumors with multiple collaterals and/or lymph nodes making the identification of the renal artery difficult...
  72. ncbi Detection of bladder cancer using a point-of-care proteomic assay
    H Barton Grossman
    Department of Urology, M D Anderson Cancer Center, Houston, Tex 77030, USA
    JAMA 293:810-6. 2005
    ..Urine tests are frequently part of an evaluation, but have either been nonspecific for cancer or required specialized analysis at a laboratory...
  73. ncbi The role of liver transplantation techniques in the surgical management of advanced renal urothelial carcinoma with or without inferior vena cava thrombus
    Wolfgang H Cerwinka
    Department of Urology, Division of Transplantation, University of Miami Miller School of Medicine, Miami, Florida, USA
    Int Braz J Urol 35:19-23. 2009
    ..The purpose of this study was to present the surgical management of large and locally-advanced urothelial tumors arising from the renal pelvis using liver transplantation techniques and to evaluate patient outcome...
  74. ncbi Total prostatectomy and lymph node dissection may be done safely without pelvic drainage: an extended experience of over 600 cases
    Nasheer Sachedina
    Department of Urology, Miller School of Medicine, University of Miami, Miami, Florida 33101, USA
    Can J Urol 16:4721-5. 2009
    ..From our experience with 846 patients, we contend that patient safety and efficacy is not compromised by selectively omitting a pelvic drain...
  75. ncbi An orally active Amazonian plant extract (BIRM) inhibits prostate cancer growth and metastasis
    Devendra S Dandekar
    Department of Urology, McKnight Vision Research Building, University of Miami School of Medicine, Miami, Florida 33101, USA
    Cancer Chemother Pharmacol 52:59-66. 2003
    ..CONCLUSION: The plant extract BIRM contains antitumor compounds of Mr >or=3500 with potent antiproliferative activity in vitro and in vivo against prostate cancer cells...
  76. ncbi Is the incidence of uretero-intestinal anastomotic stricture increased in patients undergoing radical cystectomy with previous pelvic radiation?
    Devendar Katkoori
    Department of Urology, Miller School of Medicine, University of Miami, Miami, FL, USA
    BJU Int 105:795-8. 2010
    ..Study Type - Therapy (case series) Level of Evidence 4..
  77. ncbi Does body mass index affect outcome after reconstruction of orthotopic neobladder?
    Martha A Reyes
    Department of Urology, University of Miami Miller School of Medicine, Miami, Florida 33101, USA
    Urology 69:475-8. 2007
    ..To evaluate the impact of body mass index (BMI) on outcome after orthotopic neobladder (NB) reconstruction...
  78. ncbi The emerging role of epigenetics in urological cancers
    Kavitha Ramachandran
    Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami, Florida 33101, USA
    Can J Urol 14:3535-41. 2007
    ..The emerging area of epigenetic therapy holds great promise for novel chemotherapeutic and chemoprevention approaches against cancer...
  79. ncbi Muscle-invasive urothelial carcinoma of the bladder
    S Bruce Malkowicz
    Department of Urology, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
    Urology 69:3-16. 2007
    ..Currently, no tumor markers have been prospectively validated to help guide clinical decision making, and prospective trials incorporating marker data should be encouraged...
  80. ncbi Trends in Gleason score: concordance between biopsy and prostatectomy over 15 years
    Ayyathurai Rajinikanth
    Department of Urology, University of Miami Miller School of Medicine, Miami, Florida 33101, USA
    Urology 72:177-82. 2008
    ..To assess the changes in the concordance rate of prostate biopsy and radical prostatectomy (RP) Gleason score (GS) over 15 years...
  81. ncbi Is adjuvant chemotherapy for bladder cancer safer in patients with an ileal conduit than a neobladder?
    Murugesan Manoharan
    Department of Urology, University of Miami School of Medicine, Miami, FL 33101, USA
    BJU Int 96:1286-9. 2005
    ....
  82. ncbi A pelvic drain can often be avoided after radical retropubic prostatectomy--an update in 552 cases
    Motoo Araki
    Department of Urology, Miller School of Medicine, University of Miami, Miami, Florida, USA
    Eur Urol 50:1241-7; discussion 1246-7. 2006
    ..Our 4-year experience indicates that morbidity is not increased by omitting a drain from the pelvic cavity after RRP in properly selected cases...
  83. ncbi Surgical techniques for treating a renal neoplasm invading the inferior vena cava
    Anil Vaidya
    Department of Urology, University of Miami School of Medicine, Miami, Florida, USA
    J Urol 169:435-44. 2003
    ..Hypothermic circulatory arrest should be considered when treating vena caval-atrial tumor thrombus. Surgeons familiar with liver mobilization can greatly facilitate the exposure needed for safely operating in these cases...
  84. ncbi Timing of androgen deprivation for prostate cancer: benefits versus side effects--a patient-physician dialogue
    Mark S Soloway
    Urology 60:735-7. 2002
  85. ncbi Chemotherapy for bladder cancer: treatment guidelines for neoadjuvant chemotherapy, bladder preservation, adjuvant chemotherapy, and metastatic cancer
    Cora N Sternberg
    Department of Oncology, San Camillo Forlanini Hospital, Rome, Italy
    Urology 69:62-79. 2007
    ....
  86. ncbi Progression and survival in patients with T1G3 bladder tumors
    Mark S Soloway
    Urology 59:631; author reply 631. 2002
  87. ncbi The diagnosis and staging of bladder cancer: from RBCs to TURs
    Adrienne J K Carmack
    Department of Urology, University of Miami School of Medicine, Miami, Florida 33101, USA
    Urology 67:3-8; discussion 8-10. 2006
    ..We highlight emerging areas, such as markers and fluorescence cystoscopy. Suspicion, accuracy, and technologic advances are key factors in ensuring the best outcomes for patients with bladder cancer...
  88. ncbi Secondary cancer after radiotherapy for prostate cancer: should we be more aware of the risk?
    Peter J Bostrom
    Department of Urology, University of Miami Miller School of Medicine, Miami, Florida, USA
    Eur Urol 52:973-82. 2007
    ..This report reviews the available data regarding the risk of secondary cancer after radiation for prostate cancer...
  89. ncbi Failure after radical prostatectomy
    Endre Z Neulander
    Department of Urology, Soroka Medical Center, Ben Gurion University, Beer Sheva, Israel
    Urology 61:30-6. 2003
  90. ncbi Re: can restaging transurethral resection of T1 bladder cancer select patients for immediate cystectomy? H. W. Herr, S. M. Donat and G. Dalbagni J Urol 2007; 177: 75-79
    Alan M Nieder
    J Urol 178:352. 2007
  91. ncbi Expectant management of small, recurrent, noninvasive papillary bladder tumors
    Mark S Soloway
    Department of Urology, University of Miami, Florida 33101, USA
    J Urol 170:438-41. 2003
    ..Therefore, as an alternative to in office fulguration to minimize morbidity and cost associated with repeat transurethral resection it may not be necessary to remove these tumors promptly at new tumor occurrence or recurrence...
  92. ncbi Neither alpha-blocker therapy nor cystography is required before early catheter removal after radical prostatectomy
    Alan M Nieder
    Department of Urology, University of Miami School of Medicine, Miami, Florida, USA
    BJU Int 95:323-5. 2005
    ..The addition of an alpha-blocker is unlikely to reduce the already low incidence of urinary retention...
  93. ncbi Editorial: Bladder cancer. How can we make a difference?
    Mark S Soloway
    J Urol 170:1781-2. 2003
  94. ncbi Do unto others--why I would want anesthesia for my prostate biopsy
    Mark S Soloway
    Urology 62:973-5. 2003
  95. ncbi [Future prospects for primary hormone therapy in localized and locally advanced prostate cancer]
    Hideyuki Akaza
    Department of Urology, Institute of Clinical Medicine, University of Tsukuba
    Hinyokika Kiyo 49:771-7. 2003
    ....
  96. ncbi Re: Schrier BPh, Hollander MP, van Rhijn BWG, Kiemeney LALM, Witjes JA. Prognosis of muscle-invasive bladder cancer: difference between primary and progressive tumours and implications for therapy. Eur Urol 2004;45:292-6
    Mark S Soloway
    Eur Urol 47:264; author reply 264. 2005
  97. ncbi Re: Urine based markers of urological malignancy
    Vinata B Lokeshwar
    J Urol 167:1406-7. 2002